Aims & Scope ::: Endocrine, Metabolic & Immune Disorders - Drug Targets

ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)


Volume 17, 4 Issues, 2017


Download PDF Flyer




Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders

This journal supports open access

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
Italy


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 1.897

Aims & Scope

This journal is devoted to timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Topics related to the neuroendocrine-immune axis are given special emphasis in view of the growing interest in stress-related, inflammatory, autoimmune, and degenerative disorders. Original articles related to Immune Disorders and Drug Targeting are also considered for publication.

Advertisement

Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science